谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Long-term safety and efficacy of tralokinumab in more than 1400 patients with moderate-to-severe atopic dermatitis treated for up to 42 months: an interim analysis of ECZTEND

Andrew Blauvelt,Richard Langley,Eric Simpson,Richard B. Warren,Antonio Costanzo,Hidehisa Saeki,Stine Fangel,Nathan Lassota,Anna Carlsson,Darryl Toth,Marie Tauber,Andreas Pinter,Mahreen Ameen,Kristian Reich

BRITISH JOURNAL OF DERMATOLOGY（2022）

引用 1|浏览15
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要